Home
About
Overview
Sharing Data
ORCID
Help
History (33)
Effects of combination therapy with rosuvastatin and fenofibric acid in patients with mixed dyslipidemia and high-sensitivity C-reactive protein (= 2 mg/L). cmb@bcm.tmc.edu.
Marek Disease
Cholesterol, HDL
Myelin Proteins
Safety of aggressive lipid management.
See All 33 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety of aggressive lipid management.
Safety of aggressive lipid management. J Am Coll Cardiol. 2007 May 01; 49(17):1753-62.
View in:
PubMed
subject areas
Coronary Disease
Dose-Response Relationship, Drug
Drug Therapy, Combination
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipoproteins, LDL
authors with profiles
Michael Davidson